Cartesian Therapeutics Inc
NASDAQ:RNAC

Watchlist Manager
Cartesian Therapeutics Inc Logo
Cartesian Therapeutics Inc
NASDAQ:RNAC
Watchlist
Price: 12.53 USD -5.58% Market Closed
Market Cap: 325.2m USD

Relative Value

The Relative Value of one RNAC stock under the Base Case scenario is 0.18 USD. Compared to the current market price of 12.53 USD, Cartesian Therapeutics Inc is Overvalued by 99%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RNAC Relative Value
Base Case
0.18 USD
Overvaluation 99%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
28
vs Industry
42
Median 3Y
4.4
Median 5Y
5.2
Industry
7.5
Forward
86.1
vs History
vs Industry
12
Median 3Y
-1.8
Median 5Y
-4.6
Industry
23.6
Forward
-3.8
vs History
vs Industry
Median 3Y
-6.1
Median 5Y
-4.9
Industry
20.2
vs History
vs Industry
Median 3Y
-4.9
Median 5Y
-4.3
Industry
22.9
vs History
vs Industry
53
Median 3Y
2.3
Median 5Y
-1.1
Industry
2.8
vs History
38
vs Industry
51
Median 3Y
1.7
Median 5Y
3.3
Industry
7.7
Forward
38.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.6
vs History
vs Industry
29
Median 3Y
-1.5
Median 5Y
-3.3
Industry
4.9
vs History
vs Industry
28
Median 3Y
-1.4
Median 5Y
-3.2
Industry
4.9
Forward
-1.5
vs History
vs Industry
29
Median 3Y
-2.5
Median 5Y
-2.4
Industry
5.4
vs History
vs Industry
26
Median 3Y
-2.5
Median 5Y
-2.4
Industry
4
vs History
77
vs Industry
59
Median 3Y
1.3
Median 5Y
2.8
Industry
5.1

Multiples Across Competitors

RNAC Competitors Multiples
Cartesian Therapeutics Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Cartesian Therapeutics Inc
NASDAQ:RNAC
325m USD 9.3 -7.6 -2.9 -2.8
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 139 238 -162 258.7 -197 033.9 -194 785.5
US
Abbvie Inc
NYSE:ABBV
338.1B USD 5.9 81.4 15.5 22.9
US
Amgen Inc
NASDAQ:AMGN
160.4B USD 4.7 27 14.5 23.9
US
Gilead Sciences Inc
NASDAQ:GILD
135.5B USD 4.7 22.7 9.9 13.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119B USD 10.7 -120.4 25.6 26.8
US
Epizyme Inc
F:EPE
94.1B EUR 2 063.6 -526.6 -573.4 -558.1
AU
CSL Ltd
ASX:CSL
124.4B AUD 5.3 29.4 18.1 22.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
59.5B USD 4.2 13.2 11.8 13.3
US
Seagen Inc
F:SGT
39.3B EUR 19.9 -61 -65.7 -59.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
42.3B USD 18 -156.9 -704 -352.8
P/E Multiple
Earnings Growth PEG
US
Cartesian Therapeutics Inc
NASDAQ:RNAC
Average P/E: 34.8
Negative Multiple: -7.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -162 258.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
81.4
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
27
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
22.7
189%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -120.4 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -526.6 N/A N/A
AU
CSL Ltd
ASX:CSL
29.4
16%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.2
7%
1.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -61 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -156.9 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Cartesian Therapeutics Inc
NASDAQ:RNAC
Average EV/EBITDA: 15.9
Negative Multiple: -2.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -197 033.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.5
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.5
17%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
6%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.6
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -573.4 N/A N/A
AU
CSL Ltd
ASX:CSL
18.1
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.8
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -65.7 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -704 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Cartesian Therapeutics Inc
NASDAQ:RNAC
Average EV/EBIT: 20.5
Negative Multiple: -2.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 785.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.9
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.9
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.6
11%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.8
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -558.1 N/A N/A
AU
CSL Ltd
ASX:CSL
22.6
14%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.3
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -352.8 N/A N/A